ALKS FY 2022 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B-5.3% YoY

Gross Profit

$894M80.4% margin

Operating Income

-$6M-0.5% margin

Net Income

-$158M-14.2% margin

EPS (Diluted)

$-0.97

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

-$17M

Stock-Based Comp.

$94M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$920M

Stockholders' Equity

$1.0B

Cash & Equivalents

$292M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.2B	-5.3%
Gross Profit	$894M	$976M	-8.5%
Operating Income	-$6M	$98M	-106.2%
Net Income	-$158M	-$48M	-228.6%